<DOC>
	<DOCNO>NCT01546896</DOCNO>
	<brief_summary>This research aim investigate efficacy safety buspirone treat generalize anxiety disorder depressive symptom evaluate neuroprotective effect use magnetic resonance imaging .</brief_summary>
	<brief_title>Effects Buspar Depressive Symptom Improvement Neuroprotection Patients With Anxiety Disorder</brief_title>
	<detailed_description />
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Alprazolam</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<criteria>Patient Men woman age 20 65 Diagnosis generalize anxiety disorder assess Structured Clinical Interview DSMIV ( SCIDIV ) Depressive symptom score measure Hamilton Depression Rating Scale screen baseline assessment : &gt; =8 &lt; =16 Healthy Control Subject Inclusion Criteria Healthy men woman age 20 65 Presence major physical neurological illness ( e.g.， head trauma , epilepsy， seizure， stroke， cerebral tumor， multiple sclerosis，cerebrovascular disease， narrowangle glaucoma， drug hypersensitivity， etc . ) Drug abuse past 3 month Contraindications magnetic resonance imaging ( e.g. , pacemaker implantation，claustrophobia , etc . ) Diagnosis Axis I disorder generalize anxiety disorder presence symptom require hospitalization Major depressive episode past 12 month Depressive symptom score measure Hamilton Depression Rating Scale : &gt; =17 Women pregnant , breastfeeding , plan pregnancy Contraindications drug use study ( e.g. , allergy , intolerance , etc . ) Unstable medical illness severe abnormality laboratory test screen assessment Use psychoactive medication may affect brain imaging finding Intelligence quotient 80</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>